Wednesday, November 25, 11:49 am IST
Hot Searches:  manmohan singh, infosys, kareena kapoor
| Feedback
LATEST NEWS
more..
twitter
facebook
Moneycontrol » News Center » Business » Business
Aurobindo drug gets US nod
Published on Sat, Nov 07, 2009 at 10:39   |  Updated at Sat, Nov 07, 2009 at 10:43  |  Source : Business Line
Email
Print
Blish This

Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) for Lamotrigine tablets.

The tablets are generic equivalent to Lamictal of GlaxoSmithKline and fall under central nervous system segment.


They are indicated as adjunctive therapy for partial seizures and generalised seizures of Lennox-Gastaut syndrome in patients aged two years and older and for conversion to monotherapy in adults with partial seizures.

The product would be launched soon, the Hyderabad-based company said in a release.

 

Taken from Business Line

Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
Tags: Aurobindo Pharma Ltd, US Food and Drug Administration, USFDA, Lamotrigine tablets, GlaxoSmithKline, Lamictal, adjunctive therapy, Lennox-Gastaut syndrome
Help us develop News Center
Tell us what you want!
WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
24 Hours
7 Days
1 Month
NEWS FROM OUR PARTNERS
©Network 18, 2009. All Rights Reserved